These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3260844)

  • 21. The role of Klebsiella in the pathogenesis of ankylosing spondylitis. II Evidence for a specific B27-associated marker on the lymphocytes of patients with ankylosing spondylitis.
    Geczy AF; Seager K; Bashir HV; de Vere-Tyndall A; Edmonds J
    J Clin Lab Immunol; 1980 Jan; 3(1):23-8. PubMed ID: 7381924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enteric bacteria and HLA-B27 associated cell surface modification in patients with seronegative spondarthritis.
    Edmonds J; Geczy AF; Sullivan JS; Prendergast JK; Upfold LI; Bashir HV
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):75-82. PubMed ID: 6606476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [HLA-B27 in Bechterew's disease].
    Ulvestad E
    Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1317-22. PubMed ID: 10868094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subtypes of HLA-B27 detected by cytotoxic T lymphocytes and their role in self-recognition.
    Breuning MH; Lucas CJ; Breur BS; Engelsma MY; de Lange GG; Dekker AJ; Biddison WE; Ivanyi P
    Hum Immunol; 1982 Dec; 5(4):259-68. PubMed ID: 6186653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A factor in the culture filtrate of some Klebsiella isolates specifically modifies the fibroblasts of HLA-B27-positive normal individuals.
    Rayment C; Geczy AF; Bashir HV; Edmonds JP
    Immunology; 1984 Jun; 52(2):385-7. PubMed ID: 6610633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ankylosing spondylitis, HLA-B27, and klebsiella.
    Geczy AF
    Ann Rheum Dis; 1986 Mar; 45(3):261-2. PubMed ID: 3485411
    [No Abstract]   [Full Text] [Related]  

  • 27. The modification of HLA-B27-positive lymphocytes by the culture filtrate of Klebsiella K43 BTS 1 is a metabolically active process.
    Sullivan JS; Geczy AF
    Clin Exp Immunol; 1985 Dec; 62(3):672-7. PubMed ID: 3878756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Search for cross-reactivity between HLA B27 and Klebsiella pneumoniae.
    Archer JR
    Ann Rheum Dis; 1981 Aug; 40(4):400-3. PubMed ID: 7020615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of Antienterobacteriaceae and anti-HLA-B27 antibodies in mitogen stimulated cultures of lymphocytes from patients with Reiter's syndrome and ankylosing spondylitis.
    Cavender DE; Ziff M
    J Rheumatol; 1988 Feb; 15(2):315-20. PubMed ID: 3258921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attempt to show inhibition by oxygen in the modifying factor assay.
    Archer JR; Claxson A; Edwards A; Thompson PW
    Scand J Rheumatol Suppl; 1990; 87():81-4. PubMed ID: 2259891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A factor shed by lymphoblastoid cell lines of HLA-B27 positive patients with ankylosing spondylitis, specifically modifies the cells of HLA-B27 positive normal individuals.
    Orban P; Sullivan JS; Geczy AF; Upfold LI; Coulits N; Bashir HV
    Clin Exp Immunol; 1983 Jul; 53(1):10-6. PubMed ID: 6191893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of HLA-B27 antigen subtypes from the results of lymphocyte reactions to anti-HLA-B27 sera].
    Májský A
    Vnitr Lek; 1993 Jan; 39(1):49-53. PubMed ID: 8517042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-B27 and HLA-B51 determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Behçet's disease.
    Sakly N; Boumiza R; Zrour-Hassen S; Hamzaoui A; Ben Yahia S; Amara H; Khairallah M; Mahjoub S; Bergaoui N; Ghedira I
    Ann N Y Acad Sci; 2009 Sep; 1173():564-9. PubMed ID: 19758200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blind confirmation in Leiden of Geczy factor on the cells of Dutch patients with ankylosing spondylitis.
    Geczy AF; van Leeuwen A; van Rood JJ; Ivanyi P; Breur BS; Cats A
    Hum Immunol; 1986 Nov; 17(3):239-45. PubMed ID: 3491812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunogenetic study of the HLA system in families of patients with ankylosing spondylitis].
    Grubić Z; Kerhin-Brkljacić V; Cecuk-Jelicić E; Kastelan A
    Reumatizam; 2000; 47(1):13-9. PubMed ID: 11552604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparation and clinical application of HLA-B27 antisera].
    Liu DL
    Zhonghua Yi Xue Za Zhi; 1987 Mar; 67(3):144-6. PubMed ID: 3111660
    [No Abstract]   [Full Text] [Related]  

  • 37. Gram-negative bacteria, HLA-B27 and inflammatory bowel disease.
    Pease PE; Lane MR; Chahal H; Tallack JE; Allan RN
    Br J Rheumatol; 1988; 27 Suppl 2():29-31. PubMed ID: 3261188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An HLA-B27 negative case of ankylosing spondylitis with acute iridocyclitis].
    Yoshikawa M; Nakamura S; Ohno S
    Nippon Ganka Gakkai Zasshi; 1992 Feb; 96(2):271-5. PubMed ID: 1558026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA antigens in osteitis condensans ilii and ankylosing spondylitis.
    Singal DP; de Bosset P; Gordon DA; Smythe HA; Urowitz MB; Koehler BE
    J Rheumatol Suppl; 1977; 3():105-8. PubMed ID: 266591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collagen-specific cytotoxic T lymphocyte responses in patients with ankylosing spondylitis and reactive arthritis.
    Gao XM; Wordsworth P; McMichael A
    Eur J Immunol; 1994 Jul; 24(7):1665-70. PubMed ID: 8026527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.